RadNet, Inc.RDNT
Key ratios
Operating cash flow growth
18.5%TTM
2025
28.2%2024
5.5%2023
50.9%
EPS growth
-20.1%TTM
2024
-20.1%2023
-72.4%
FCF / Sales
3.2%TTM
2025
4.2%2024
2.5%2023
2.7%
Net margin
-0.9%TTM
2025
-0.9%2024
0.2%2023
0.2%
ROA
1.7%TTM
2025
1.6%2024
2.4%2023
2.1%
ROE
1.5%TTM
2025
1.4%2024
4.0%2023
4.7%
Revenue growth
18.9%TTM
2025
11.5%2024
13.2%2023
13.1%
Recent news
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA and Revises Upwards 2026 Financial Guidance Ranges
Track RDNT in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer